10-QPeriod: Q1 FY2023

ECOLAB INC. Quarterly Report for Q1 Ended Mar 31, 2023

Filed May 4, 2023For Securities:ECL

Summary

Ecolab Inc. reported strong first-quarter 2023 results, demonstrating resilience and growth in a dynamic economic environment. Net sales increased by 9% year-over-year to $3.57 billion, driven by a 13% increase in organic sales, indicating robust underlying business performance. This growth was primarily fueled by effective pricing strategies across all segments, which more than offset increased delivered product costs. The company's operating income saw a significant increase of 38% to $351.6 million, reflecting improved operational efficiencies and strong sales execution. The company's diversified business segments, including Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences, all contributed positively to the top-line growth, with particular strength noted in water treatment, food & beverage, and life sciences. Despite inflationary pressures and foreign currency headwinds, Ecolab maintained a disciplined approach to cost management and strategic investments, leading to a notable improvement in profitability. The company's balance sheet remains solid, with sufficient liquidity to support ongoing operations and strategic initiatives.

Financial Highlights

53 data points
Beta

Revenue

$3.57B

38.3% Gross Margin

Net Income

$233.40M

6.5% Net Margin

EPS (Diluted)

$0.82

Total Assets

$21.25B

Cash & Equivalents

$419.40M

Free Cash Flow

$24.50M

Financial Statements
Beta
Revenue$3.57B
Cost of Revenue$2.21B
Gross Profit$1.37B
SG&A Expenses$990.30M
Operating Income$351.60M
Interest Expense$80.10M
Net Income$233.40M
EPS (Basic)$0.82
EPS (Diluted)$0.82
Shares Outstanding (Basic)284.60M
Shares Outstanding (Diluted)285.90M

Key Highlights

  • 1Net sales increased by 9% to $3.57 billion in Q1 2023, with organic sales growing by 13%.
  • 2Operating income surged by 38% to $351.6 million, indicating strong profitability improvement.
  • 3All key segments (Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences) showed organic sales growth, demonstrating broad-based demand.
  • 4Gross margin improved to 38.3% from 36.5% in the prior year period, driven by effective pricing strategies.
  • 5The company maintained disciplined cost management, with SG&A as a percentage of sales decreasing slightly year-over-year.
  • 6Ecolab generated strong operating cash flow of $198.2 million, supporting investments and shareholder returns.
  • 7The company continues to manage its debt effectively, with a net debt to EBITDA ratio of 3.1 as of March 31, 2023.

Frequently Asked Questions

Ecolab anticipates a challenging macroeconomic environment, particularly in Europe, due to ongoing inflationary pressures and geopolitical instability. However, the company expects continued growth driven by its diversified segments and effective pricing strategies. Management is focused on navigating these challenges while continuing to invest in the business and return capital to shareholders.

Ecolab effectively managed rising delivered product costs and supply chain challenges through strong pricing initiatives across all segments. These pricing actions more than offset the increased costs, leading to an improvement in gross margin. The company also focused on operational efficiencies and productivity gains.

Foreign currency had an unfavorable impact on reported sales and operating income. The company strategically uses hedging instruments to mitigate some of this risk. Management evaluates performance on a fixed currency basis to better understand underlying operational trends, which showed stronger growth than reported results.

Ecolab recorded $27.7 million in total special charges in the first quarter of 2023, a decrease from $77.0 million in the prior year period. These charges are primarily related to restructuring activities, integration costs, and geopolitical events. The company has an ongoing 'Combined Program' expected to incur significant charges but aims to deliver substantial cost savings.